In Vitro Effects of the Second-Generation Proteasome Inhibitor Carfilzomib on Human Monocyte-Derived Dendritic Cells

DSpace Repository

In Vitro Effects of the Second-Generation Proteasome Inhibitor Carfilzomib on Human Monocyte-Derived Dendritic Cells

Dahlfrancis, Philipp Marius Christopher Edward
Dateien:
Thumbnail
2.52 MB
PDF
URI: http://hdl.handle.net/10900/100776
http://nbn-resolving.de/urn:nbn:de:bsz:21-dspace-1007764
http://dx.doi.org/10.15496/publikation-42156
http://nbn-resolving.org/urn:nbn:de:bsz:21-dspace-1007765
http://nbn-resolving.org/urn:nbn:de:bsz:21-dspace-1007767
Dokumentart: PhDThesis
Date: 2020-05-19
Language: English
Faculty: 4 Medizinische Fakultät
Department: Medizin
Advisor: Grünebach, Frank (PD Dr. rer. nat.)
Day of Oral Examination: 2020-01-16
DDC Classifikation: 610 - Medicine and health
Keywords: Dendritische Zelle , Immunologie , Onkologie
Other Keywords: Carfilzomib
Immunology
Monocyte-Derived Dendritic Cells
License: http://tobias-lib.uni-tuebingen.de/doku/lic_mit_pod.php?la=de http://tobias-lib.uni-tuebingen.de/doku/lic_mit_pod.php?la=en
Order a printed copy: Print-on-Demand
Show full item record

Abstract:

The objective of this project was on discovering a possible change in the MoDC phenotype and function due to carfilzomib exposure. MoDC function was tested with regard to cell viability, cytokine secretion and migration.

This item appears in the following Collection(s)